Activity Stream
@moatrx
• one week ago
Posted a new blog:
UK MYASTHENIA GRAVIS LAUNCH READINESS
UK MYASTHENIA GRAVIS LAUNCH READINESS
NICE's eculizumab appraisal was terminated before any cost-effectiveness review ran, leaving 2,000 to 3,000 UK gMG patients without a commissioned biologic....
